Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2003-08-08
2008-08-19
Jiang, Shaojia Anna (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S023000, C514S025000, C514S042000, C549S028000, C536S004100, C536S022100
Reexamination Certificate
active
07414072
ABSTRACT:
There is provided a 5-thio-β-D-glucopyranoside compound of the following formula, which has an inhibitory effect on SGLT2 activity, or a pharmaceutically acceptable salt thereof or a hydrate thereof. There is also provided a pharmaceutical preparation, particularly a prophylactic or therapeutic agent for diabetes, diabetes-related diseases or diabetic complications, which comprises such a compound as an active ingredient.
REFERENCES:
patent: 2004/0063646 (2004-04-01), Fujikura et al.
patent: 2006/0194809 (2006-08-01), Kakinuma et al.
patent: 0850948 (1998-07-01), None
patent: 1213296 (2002-06-01), None
patent: 1272584 (2003-01-01), None
patent: 1338603 (2003-08-01), None
patent: 1 405 859 (2004-04-01), None
patent: 10-237089 (1998-09-01), None
patent: 01/16147 (2001-03-01), None
patent: 01/68660 (2001-09-01), None
patent: 01/74834 (2001-10-01), None
patent: 01/74835 (2001-10-01), None
patent: 02/36602 (2002-05-01), None
patent: 02/053573 (2002-07-01), None
patent: 03/000712 (2003-01-01), None
patent: 2004/089967 (2004-10-01), None
Yuasa et al., Relative Nucleophilicity of the Two Sulfur Atoms in 1,5-Dithioglucopyranoside, Angewandte Chemie, Internation Edition in English, 36(8), pp. 868-870, 1997.
Silverman et al., The organic Chemistry of Drug Design and Drug Action, pp. 19-23.
Bozo, E., et al. “Synthesis of 4-cyanophenyl and 4-nitrophenyl 1,5-dithio-L- and -D-arabinopyranosides possessing antithrombotic activity1.2”.,Carbohydrate Research, 1998, 311, pp. 191-202.
Randell, K.D., et al. Synthesis and glycosides inhibitory activity of 5-thioglucopyranosylamines. Molecular modeling of complexes with glucoamilase.,Carbohydrate Research, 1999, 321, pp. 143-156.
Yuasa, H., et al. Relative Nucleophilicity of the Two Sulfur Atoms in 1,5-Dithioglucopyranoside.,Angew. Chem. Int. Ed. Engl., 1997, 36, No. 8, pp. 868-870.
Supplementary European Search Report with mail date Apr. 2, 2007 for EP 03 78 4623.
Asanuma Hajime
Kakinuma Hiroyuki
Sato Masakazu
Jiang Shaojia Anna
McIntosh III Traviss C.
Sughrue & Mion, PLLC
Taisho Pharmaceutical Co. Ltd.
LandOfFree
Aryl 5-thio-β-d-glucopyranoside derivatives and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aryl 5-thio-β-d-glucopyranoside derivatives and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aryl 5-thio-β-d-glucopyranoside derivatives and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4011036